The Valley Desk

ReviewInternational journal of molecular sciencesPublished

Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
International journal of molecular sciences
Published
Subject terms
Animals; Humans; Neoplasms; Antineoplastic Agents; Protein Kinase Inhibitors; Signal Transduction; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Molecular Targeted Therapy; Phosphoinositide-3 Kinase Inhibitors; EGFR; PTEN
PubMed ID
40943615
PubMed Central ID
PMC12428904
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal